A potential role for zinc alterations in the pathogenesis of Alzheimer's disease

BioFactors

Volumn 38, Issue 2, 2012, Pages 98-106

  Lyubartseva, Ganna ^a   Lovell, Mark A ^b,c  

^a SOUTHERN ARKANSAS UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid beta peptide; Mild clinical impairment; Preclinical Alzheimer's disease; Zinc; Zinc transporter proteins

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CLIOQUINOL; METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; METALLOTHIONEIN IV; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZINC TRANSPORTER 1; ZINC TRANSPORTER 2; ZINC TRANSPORTER 3; ZINC TRANSPORTER 4; ZINC TRANSPORTER 5; ZINC TRANSPORTER 6; ZINC TRANSPORTER 7;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN REGION; DISABILITY; DISEASE COURSE; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; INFERIOR PARIETAL LOBULE; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CARRIER PROTEINS; HUMANS; ZINC;

EID: 84859435848     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.199     Document Type: Review

References (117)

1. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., and Evans, D. A. ( 2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119-1122.
2. Hoyert, D. L., Heron, M. P., Murphy, S. L., and Kung, H. C. ( 2006) Deaths: final data for 2003. Natl. Vital Stat. Rep. 54, 1-120.
3. Yaari, R. and Corey-Bloom, J. ( 2007) Alzheimer's disease. Semin. Neurol. 27, 32-41.
4. Burns, A. and Iliffe, S. ( 2009) Alzheimer's disease. BMJ 338, b158.
5. Brookmeyer, R., Corrada, M. M., Curriero, F. C., and Kawas, C. ( 2002) Survival following a diagnosis of Alzheimer disease. Arch. Neurol. 59, 1764-1767.
6. Fagan, A. M., Csernansky, C. A., Morris, J. C., and Holtzman, D. M. ( 2005) Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J. Alzheimers Dis. 8, 347-358.
7. Lange, K. L., Bondi, M. W., Salmon, D. P., Galasko, D., Delis, D. C., Thomas, R. G., and Thal, L. J. ( 2002) The search for antecedent biomarkers of Alzheimer's disease. J. Int. Neuropsychol. Soc. 8, 943-955.
8. Braak, H. and Braak, E. ( 1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357.
9. Morris, J. C. and Price, A. L. ( 2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17, 101-118.
10. Flicker, C., Ferris, S. H., and Reisberg, B. ( 1991) Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41, 1006-1009.
11. Petersen, R. C. ( 2007) The current status of mild cognitive impairment--what do we tell our patients? Nat. Clin. Pract. Neurol. 3, 60-61.
12. Spaan, P. E., Raaijmakers, J. G., and Jonker, C. ( 2003) Alzheimer's disease versus normal ageing: a review of the efficiency of clinical and experimental memory measures. J. Clin. Exp. Neuropsychol. 25, 216-233.
13. Galvin, J. E., Powlishta, K. K., Wilkins, K., McKeel, D. W., Jr., Xiong, C., Grant, E., Storandt, M., and Morris, J. C. ( 2005) Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch. Neurol. 62, 758-765.
14. Knopman, D. S., Parisi, J. E., Salviati, A., Floriach-Robert, M., Boeve, B. F., Ivnik, R. J., Smith, G. E., Dickson, D. W., Johnson, K. A., Petersen, L. E., McDonald, W. C., Braak, H., and Petersen, R. C. ( 2003) Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62, 1087-1095.
15. Zhang, M. Y., Katzman, R., Salmon, D., Jin, H., Cai, G. J., Wang, Z. Y., Qu, G. Y., Grant, I., Yu, E., Levy, P., Klauber, M. R., and Liu, W. T. ( 1990) The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol. 27, 428-437.
16. Riley, K. P., Snowdon, D. A., Desrosiers, M. F., and Markesbery, W. R. ( 2005) Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol. Aging 26, 341-347.
17. Snowdon, D. A., Greiner, L. H., and Markesbery, W. R. ( 2000) Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study. Ann. NY Acad. Sci. 903, 34-38.
18. Fleminger, S. ( 2008) Long-term psychiatric disorders after traumatic brain injury. Eur. J. Anaesthesiol. Suppl. 42, 123-130.
19. Mortimer, J. A., van Duijn, C. M., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A., Shalat, S. L., and Soininen, H. ( 1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20 ( Suppl 2), S28-S35.
20. Iadecola, C., Park, L., and Capone, C. ( 2009) Threats to the mind: aging, amyloid, and hypertension. Stroke 40, S40-S44.
21. Irie, F., Fitzpatrick, A. L., Lopez, O. L., Kuller, L. H., Peila, R., Newman, A. B., and Launer, L. J. ( 2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch. Neurol. 65, 89-93.
22. Leontjevas, R., van Hooren, S., and Mulders, A. ( 2009) The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia. Am. J. Geriatr. Psychiatry 17, 56-64.
23. Xie, Z. and Tanzi, R. E. ( 2006) Alzheimer's disease and post-operative cognitive dysfunction. Exp. Gerontol. 41, 346-359.
24. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. ( 1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
25. Markesbery, W. R. ( 1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
26. Cuajungco, M. P. and Faget, K. Y. ( 2003) Zinc takes the center stage: its paradoxical role in Alzheimer's disease. Brain Res. Brain Res. Rev. 41, 44-56.
27. Andrasi, E., Farkas, E., Scheibler, H., Reffy, A., and Bezur, L. ( 1995) Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Arch. Gerontol. Geriatrics 21, 89-97.
28. Frederickson, C. J., Klitenick, M. A., Manton, W. I., and Kirkpatrick, J. B. ( 1983) Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res. 273, 335-339.
29. Frederickson, C. J., Koh, J. Y., and Bush, A. I. ( 2005) The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6, 449-462.
30. Capasso, M., Jeng, J. M., Malavolta, M., Mocchegiani, E., and Sensi, S. L. ( 2005) Zinc dyshomeostasis: a key modulator of neuronal injury. J. Alzheimers Dis. 8, 93-108; discussion 209-115.
31. Frazzini, V., Rockabrand, E., Mocchegiani, E., and Sensi, S. L. ( 2006) Oxidative stress and brain aging: is zinc the link? Biogerontology 7, 307-314.
32. Vallee, B. L. and Falchuk, K. H. ( 1993) The biochemical basis of zinc physiology. Physiol. Rev. 73, 79-118.
33. Beyersmann, D. and Haase, H. ( 2001) Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 14, 331-341.
34. Frederickson, C. J. ( 1989) Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31, 145-238.
35. Ehmann, W. D., Markesbery, W. R., Alauddin, M., Hossain, T. I., and Brubaker, E. H. ( 1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 195-206.
36. Assaf, S. Y. and Chung, S. H. ( 1984) Release of endogenous Zn2+ from brain tissue during activity. Nature 308, 734-736.
37. Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., and Li, Q. X. ( 2005) Metals and amyloid-beta in Alzheimer's disease. Int. J. Exp. Pathol. 86, 147-159.
38. Zatta, P., Lucchini, R., van Rensburg, S. J., and Taylor, A. ( 2003) The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res. Bull. 62, 15-28.
39. Takeda, A., Tamano, H., Tochigi, M., and Oku, N. ( 2005) Zinc homeostasis in the hippocampus of zinc-deficient young adult rats. Neurochem. Int. 46, 221-225.
40. Chowanadisai, W., Kelleher, S. L., and Lonnerdal, B. ( 2005) Zinc deficiency is associated with increased brain zinc import and LIV-1 expression and decreased ZnT-1 expression in neonatal rats. J. Nutr. 135, 1002-1007.
41. Cousins, R. J., Liuzzi, J. P., and Lichten, L. A. ( 2006) Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281, 24085-24089.
42. Kagi, J. H. and Schaffer, A. ( 1988) Biochemistry of metallothionein. Biochemistry 27, 8509-8515.
43. Ebadi, M., Iversen, P. L., Hao, R., Cerutis, D. R., Rojas, P., Happe, H. K., Murrin, L. C., and Pfeiffer, R. F. ( 1995) Expression and regulation of brain metallothionein. Neurochem. Int. 27, 1-22.
44. Palmiter, R. D., Findley, S. D., Whitmore, T. E., and Durnam, D. M. ( 1992) MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA 89, 6333-6337.
45. Quaife, C. J., Findley, S. D., Erickson, J. C., Froelick, G. J., Kelly, E. J., Zambrowicz, B. P., and Palmiter, R. D. ( 1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33, 7250-7259.
46. Gaither, L. A. and Eide, D. J. ( 2000) Functional expression of the human hZIP2 zinc transporter. J. Biol. Chem. 275, 5560-5564.
47. Gaither, L. A. and Eide, D. J. ( 2001) The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells. J. Biol. Chem. 276, 22258-22264.
48. Cao, J., Bobo, J. A., Liuzzi, J. P., and Cousins, R. J. ( 2001) Effects of intracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis. J. Leukoc. Biol. 70, 559-566.
49. Cousins, R. J., Blanchard, R. K., Popp, M. P., Liu, L., Cao, J., Moore, J. B., and Green, C. L. ( 2003) A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc. Natl. Acad. Sci. USA 100, 6952-6957.
50. Wang, K., Zhou, B., Kuo, Y. M., Zemansky, J., and Gitschier, J. ( 2002) A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71, 66-73.
51. Wang, F., Kim, B. E., Petris, M. J., and Eide, D. J. ( 2004) The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J. Biol. Chem. 279, 51433-51441.
52. Taylor, K. M., Morgan, H. E., Johnson, A., Hadley, L. J., and Nicholson, R. I. ( 2003) Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. Biochem. J. 375, 51-59.
53. Liuzzi, J. P. and Cousins, R. J. ( 2004) Mammalian zinc transporters. Ann. Rev. Nutr. 24, 151-172.
54. Palmiter, R. D. and Findley, S. D. ( 1995) Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. Embo. J. 14, 639-649.
55. Palmiter, R. D. and Huang, L. ( 2004) Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch. 447, 744-751.
56. Sekler, I., Moran, A., Hershfinkel, M., Dori, A., Margulis, A., Birenzweig, N., Nitzan, Y., and Silverman, W. F. ( 2002) Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J. Comp. Neurol. 447, 201-209.
57. Lovell, M. A., Smith, J. L., Xiong, S., and Markesbery, W. R. ( 2005) Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox. Res. 7, 265-271.
58. Takeda, A. ( 2000) Movement of zinc and its functional significance in the brain. Brain Res. Brain Res. Rev. 34, 137-148.
59. Ohana, E., Sekler, I., Kaisman, T., Kahn, N., Cove, J., Silverman, W. F., Amsterdam, A., and Hershfinkel, M. ( 2006) Silencing of ZnT-1 expression enhances heavy metal influx and toxicity. J. Mol. Med. 84, 753-763.
60. Palmiter, R. D., Cole, T. B., and Findley, S. D. ( 1996) ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. Embo. J. 15, 1784-1791.
61. Liuzzi, J. P., Blanchard, R. K., and Cousins, R. J. ( 2001) Differential regulation of zinc transporter 1, 2, and 4 mRNA expression by dietary zinc in rats. J. Nutr. 131, 46-52.
62. Palmiter, R. D., Cole, T. B., Quaife, C. J., and Findley, S. D. ( 1996) ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc. Natl. Acad. Sci. USA 93, 14934-14939.
63. McMahon, R. J. and Cousins, R. J. ( 1998) Mammalian zinc transporters. J. Nutr. 128, 667-670.
64. Gosavi, N., Lee, H. J., Lee, J. S., Patel, S., and Lee, S. J. ( 2002) Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277, 48984-48992.
65. Friedlich, A. L., Lee, J. Y., van Groen, T., Cherny, R. A., Volitakis, I., Cole, T. B., Palmiter, R. D., Koh, J. Y., and Bush, A. I. ( 2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J. Neurosci. 24, 3453-3459.
66. Huang, L. and Gitschier, J. ( 1997) A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat. Gene. 17, 292-297.
67. Smith, J. L., Xiong, S., Markesbery, W. R., and Lovell, M. A. ( 2006) Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience 140, 879-888.
68. Kambe, T., Narita, H., Yamaguchi-Iwai, Y., Hirose, J., Amano, T., Sugiura, N., Sasaki, R., Mori, K., Iwanaga, T., and Nagao, M. ( 2002) Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J. Biol. Chem. 277, 19049-19055.
69. Huang, L., Kirschke, C. P., and Gitschier, J. ( 2002) Functional characterization of a novel mammalian zinc transporter, ZnT6. J. Biol. Chem. 277, 26389-26395.
70. Lovell, M. A., Smith, J. L., and Markesbery, W. R. ( 2006) Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease. J. Neuropathol. Exp. Neurol. 65, 489-498.
71. Lyubartseva, G., Smith, J. L., Markesbery, W. R., and Lovell, M. A. ( 2010) Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain. Brain Pathol. 20, 343-350.
72. Kirschke, C. P. and Huang, L. ( 2003) ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J. Biol. Chem. 278, 4096-4102.
73. Kleineke, J. W. and Brand, I. A. ( 1997) Rapid changes in intracellular Zn2+ in rat hepatocytes. J. Pharmacol. Toxicol. Methods 38, 181-187.
74. Rivlin, A. A., Chan, Y. L., and Wool, I. G. ( 1999) The contribution of a zinc finger motif to the function of yeast ribosomal protein YL37a. J. Mol. Biol. 294, 909-919.
75. Overbeck, S., Uciechowski, P., Ackland, M. L., Ford, D., and Rink, L. ( 2008) Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J. Leukoc. Biol. 83, 368-380.
76. Kelleher, S. L., Velasquez, V., Croxford, T. P., McCormick, N. H., Lopez, V., and MacDavid, J. ( 2012) Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation. J. Cell. Physiol. 227, 1761-1770.
77. Seve, M., Chimienti, F., Devergnas, S., and Favier, A. ( 2004) In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 5, 32.
78. Yokoyama, M., Koh, J., and Choi, D. W. ( 1986) Brief exposure to zinc is toxic to cortical neurons. Neurosci. Lett. 71, 351-355.
79. Ducray, A., Bondier, J. R., Michel, G., Bon, K., Millot, J. L., Propper, A., and Kastner, A. ( 2002) Recovery following peripheral destruction of olfactory neurons in young and adult mice. Eur. J. Neurosci. 15, 1907-1917.
80. Sensi, S. L., Canzoniero, L. M., Yu, S. P., Ying, H. S., Koh, J. Y., Kerchner, G. A., and Choi, D. W. ( 1997) Measurement of intracellular free zinc in living cortical neurons: routes of entry. J. Neurosci. 17, 9554-9564.
81. Lovell, M. A. ( 2009) A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J. Alzheimers Dis. 16, 471-483.
82. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., and Ward, P. J. ( 1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248, 1122-1124.
83. Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K., and Masters, C. L. ( 1993) A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109-16112.
84. Bush, A. I., Pettingell, W. H., Multhaup, G., d Paradis, M., Vonsattel, J. P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. ( 1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467.
85. Liu, S. T., Howlett, G., and Barrow, C. J. ( 1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38, 9373-9378.
86. An, W. L., Bjorkdahl, C., Liu, R., Cowburn, R. F., Winblad, B., and Pei, J. J. ( 2005) Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells. J. Neurochem. 92, 1104-1115.
87. Cardoso, S. M., Rego, A. C., Pereira, C., and Oliveira, C. R. ( 2005) Protective effect of zinc on amyloid-beta 25-35 and 1-40 mediated toxicity. Neurotox Res. 7, 273-281.
88. Lovell, M. A., Xie, C., and Markesbery, W. R. ( 1999) Protection against amyloid beta peptide toxicity by zinc. Brain Res. 823, 88-95.
89. Cuajungco, M. P., Goldstein, L. E., Nunomura, A., Smith, M. A., Lim, J. T., Atwood, C. S., Huang, X., Farrag, Y. W., Perry, G., and Bush, A. I. ( 2000) Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J. Biol. Chem. 275, 19439-19442.
90. Deng, Q. S., Turk, G. C., Brady, D. R., and Smith, Q. R. ( 1994) Evaluation of brain element composition in Alzheimer's disease using inductively coupled plasma mass spectrometry. Neurobiol. Aging S113, 464.
91. Panayi, A. E., Spyrou, N. M., Iversen, B. S., White, M. A., and Part, P. ( 2002) Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J. Neurol. Sci. 195, 1-10.
92. Deibel, M. A., Ehmann, W. D., and Markesbery, W. R. ( 1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143, 137-142.
93. Cornett, C. R., Markesbery, W. R., and Ehmann, W. D. ( 1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
94. Danscher, G., Jensen, K. B., Frederickson, C. J., Kemp, K., Andreasen, A., Juhl, S., Stoltenberg, M., and Ravid, R. ( 1997) Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J. Neurosci. Methods 76, 53-59.
95. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. ( 1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
96. Miller, L. M., Wang, Q., Telivala, T. P., Smith, R. J., Lanzirotti, A., and Miklossy, J. ( 2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155, 30-37.
97. Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B., Naslund, J., and Bush, A. I. ( 2006) Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75.
98. Molina, J. A., Jimenez-Jimenez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., Gonzalez-Munoz, M. J., de Bustos, F., Porta, J., Orti-Pareja, M., Zurdo, M., Barrios, E., and Martinez-Para, M. C. ( 1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural. Transm. 105, 479-488.
99. Shore, D., Henkin, R. I., Nelson, N. R., Agarwal, R. P., and Wyatt, R. J. ( 1984) Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia. J. Am. Geriatr. Soc. 32, 892-895.
100. Gonzalez, C., Martin, T., Cacho, J., Brenas, M. T., Arroyo, T., Garcia-Berrocal, B., Navajo, J. A., and Gonzalez-Buitrago, J. M. ( 1999) Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur. J. Clin. Invest. 29, 637-642.
101. Rulon, L. L., Robertson, J. D., Lovell, M. A., Deibel, M. A., Ehmann, W. D., and Markesber, W. R. ( 2000) Serum zinc levels and Alzheimer's disease. Biol. Trace Elem. Res. 75, 79-85.
102. Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., and Cuny, G. ( 1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282.
103. Dong, J., Robertson, J. D., Markesbery, W. R., and Lovell, M. A. ( 2008) Serum zinc in the progression of Alzheimer's disease. J. Alzheimers Dis. 15, 443-450.
104. Hershey, C. O., Hershey, L. A., Varnes, A., Vibhakar, S. D., Lavin, P., and Strain, W. H. ( 1983) Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology 33, 1350-1353.
105. Palm, R., Strand, T., and Hallmans, G. ( 1986) Zinc, total protein, and albumin in CSF of patients with cerebrovascular diseases. Acta. Neurol. Scand. 74, 308-313.
106. Basun, H., Forssell, L. G., Wetterberg, L., and Winblad, B. ( 1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural. Transm. Park Dis. Dement. Sect. 3, 231-258.
107. Gerhardsson, L., Lundh, T., Minthon, L., and Londos, E. ( 2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 25, 508-515.
108. Wilquet, V. and De Strooper, B. ( 2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 14, 582-588.
109. Bush, A. I., Pettingell, W. H., Paradis, M. D., and Tanzi, R. ( 1995) Zinc and Alzheimer's disease. Science 268, 1921-1923.
110. Bush, A. I. ( 2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207-214.
111. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., and Bush, A. I. ( 2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
112. Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q. X., Tammer, A., Carrington, D., Mavros, C., Volitakis, I., Xilinas, M., Ames, D., Davis, S., Beyreuther, K., Tanzi, R. E., and Masters, C. L. ( 2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685-1691.
113. Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., Wilson, J., and Ritchie, C. W. ( 2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 7, 779-786.
114. Rodriguez-Rodriguez, C., Sanchez de Groot, N., Rimola, A., Alvarez-Larena, A., Lloveras, V., Vidal-Gancedo, J., Ventura, S., Vendrell, J., Sodupe, M., and Gonzalez-Duarte, P. ( 2009) Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. J. Am. Chem. Soc. 131, 1436-1451.
115. Zhang, L. H., Wang, X., Stoltenberg, M., Danscher, G., Huang, L., and Wang, Z. Y. ( 2008) Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Res. Bull. 77, 55-60.
116. Lee, J. Y., Cole, T. B., Palmiter, R. D., Suh, S. W., and Koh, J. Y. ( 2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. USA 99, 7705-7710.
117. Zhang, L. H., Wang, X., Zheng, Z. H., Ren, H., Stoltenberg, M., Danscher, G., Huang, L., Rong, M., and Wang, Z. Y. ( 2010) Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol. Aging 31, 74-87.